IBO
Impact BioMedical, Inc.
AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY
$0.66
-2.59% today
Updated 2026-05-01
Market cap
$71.16M
P/E ratio
—
P/S ratio
2,223.81x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $2
Volume
5.4M
Impact BioMedical, Inc. (IBO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $405600.00 | $320661.00 | $217207.00 | $116615.00 | $72744.00 | $3.99M | $46.50M | $44.63M | $20.29M |
| Cash & equivalents | $387750.00 | $51922.00 | $204929.00 | $97666.00 | $52136.00 | $142196.00 | $2000.00 | $1000.00 | $2.00M |
| Current assets | $405600.00 | $320661.00 | $217207.00 | $115341.00 | $71699.00 | $901543.00 | $122000.00 | $332000.00 | $2.45M |
| Total liabilities | $5600.00 | $25437.00 | $20092.00 | $21724.00 | $78027.00 | $1.05M | $13.83M | $16.37M | $13.05M |
| Current liabilities | $5600.00 | $25437.00 | $20092.00 | $21724.00 | $18027.00 | $987869.00 | $10.59M | $13.14M | $9.79M |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $400000.00 | $295224.00 | $197115.00 | $94891.00 | $-5283.00 | $2.94M | $29.56M | $25.22M | $4.26M |
| Retained earnings | — | $-408289.00 | $-506398.00 | $-624707.00 | $-831931.00 | $-12.25M | $-8.63M | $-12.96M | $-37.67M |
| Accounts receivable | $850.00 | $28619.00 | $4378.00 | $35191.00 | $14063.00 | $113497.00 | $16000.00 | $331000.00 | $184000.00 |
| Inventory | — | — | — | — | — | — | — | — | $-265.00 |
| Goodwill | — | — | — | — | $31928.00 | $25093.00 | $25.09M | $25.09M | $17.79M |